Collection of the Thrombo-VaxCov Cohort

Recruiting

• Conditions: Venous Thrombosis; Thrombocytopenia; Vaccination; Complications; SARS-CoV Infection; Covid19
• Interventions: Other: Retrospective data and biological samples

• Registration Number: NCT04889326
• Lead Sponsor: University Hospital, Lille

Brief Summary

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation.

This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.

Detailed Description

In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after anti-Covid vaccination.

Study Timeline

• Study Start: 2021-04-02
• Study First Submitted: 2021-04-27
• Study First Submitted QC: 2021-05-11
• Study First Posted: 2021-05-17
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-17
• Last Update Posted: 2023-01-18
• Primary Completion: 2023-05
• Study Completion: 2023-05

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

atypical thrombosis symptoms onset within 4 weeks of vaccination

Exclusion Criteria

children

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patient hospitalized with atypical thrombosis within 4 weeks of anti-covid vaccination	Retrospective data and biological samples	-

Primary Outcome Measures

Name	Time	Method
Functional outcome (modified rankin scale)	through study completion, an average of 1 years

Secondary Outcome Measures

Name	Time	Method
Recurrent vascular events	through study completion, an average of 1 years
Mortality	through study completion, an average of 1 years

Trial Locations

Locations (1)

CHU lille; 🇫🇷 Lille, France